CLDX
Price
$19.53
Change
-$0.14 (-0.71%)
Updated
Jun 5 closing price
Capitalization
1.3B
62 days until earnings call
HOWL
Price
$1.24
Change
+$0.01 (+0.81%)
Updated
Jun 6, 10:31 AM (EDT)
Capitalization
55.19M
62 days until earnings call
Interact to see
Advertisement

CLDX vs HOWL

Header iconCLDX vs HOWL Comparison
Open Charts CLDX vs HOWLBanner chart's image
Celldex Therapeutics
Price$19.53
Change-$0.14 (-0.71%)
Volume$667.72K
Capitalization1.3B
Werewolf Therapeutics
Price$1.24
Change+$0.01 (+0.81%)
Volume$370
Capitalization55.19M
CLDX vs HOWL Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. HOWL commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and HOWL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CLDX: $19.52 vs. HOWL: $1.23)
Brand notoriety: CLDX and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 69% vs. HOWL: 141%
Market capitalization -- CLDX: $1.3B vs. HOWL: $55.19M
CLDX [@Biotechnology] is valued at $1.3B. HOWL’s [@Biotechnology] market capitalization is $55.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, HOWL is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 4 TA indicator(s) are bullish while HOWL’s TA Score has 5 bullish TA indicator(s).

  • CLDX’s TA Score: 4 bullish, 4 bearish.
  • HOWL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -1.61% price change this week, while HOWL (@Biotechnology) price change was -3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

HOWL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.3B) has a higher market cap than HOWL($55.2M). HOWL YTD gains are higher at: -16.892 vs. CLDX (-22.754). HOWL has higher annual earnings (EBITDA): -65.72M vs. CLDX (-213.94M). CLDX has more cash in the bank: 673M vs. HOWL (92M). CLDX has less debt than HOWL: CLDX (3.43M) vs HOWL (37M). CLDX has higher revenues than HOWL: CLDX (7.56M) vs HOWL (1.14M).
CLDXHOWLCLDX / HOWL
Capitalization1.3B55.2M2,348%
EBITDA-213.94M-65.72M326%
Gain YTD-22.754-16.892135%
P/E RatioN/AN/A-
Revenue7.56M1.14M661%
Total Cash673M92M732%
Total Debt3.43M37M9%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXHOWL
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGDCX28.09N/A
N/A
Neuberger Berman Large Cap Growth C
AFOYX15.62N/A
N/A
Ariel Focus Institutional
FNGZX18.16N/A
N/A
Franklin Intl Growth Adv
VEVRX44.81N/A
N/A
Victory Sycamore Established Value R6
HSLTX43.50N/A
N/A
Hartford Small Cap Growth R5

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-0.76%
BEAM - CLDX
52%
Loosely correlated
-0.87%
DNLI - CLDX
49%
Loosely correlated
-1.35%
KYMR - CLDX
49%
Loosely correlated
+7.68%
RVMD - CLDX
49%
Loosely correlated
-0.42%
CRNX - CLDX
48%
Loosely correlated
+0.59%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-6.11%
GBIO - HOWL
43%
Loosely correlated
-5.63%
CLDX - HOWL
40%
Loosely correlated
-0.76%
IPSC - HOWL
39%
Loosely correlated
-0.71%
ABOS - HOWL
39%
Loosely correlated
-0.47%
VSTM - HOWL
38%
Loosely correlated
+0.16%
More